Neochem Bio Solutions is set to debut on the NSE SME platform on December 9, with its IPO seeing strong subscription despite a muted grey market. The company, a player in speciality performance chemicals with over 350 formulations, reported significant profit growth. Funds raised will bolster working capital and repay debt, positioning Neochem for a steady market entry.